ZYUS Life Sciences Corporation
ZYUS.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.68M | -24.39M | -26.86M | -27.12M | -30.36M |
| Total Depreciation and Amortization | 2.11M | 2.16M | 2.19M | 2.23M | 2.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.00M | 13.78M | 14.95M | 14.63M | 18.06M |
| Change in Net Operating Assets | 1.39M | 1.07M | 4.11M | -678.00K | -4.15M |
| Cash from Operations | -7.18M | -7.37M | -5.61M | -10.93M | -14.30M |
| Capital Expenditure | -8.80K | -34.00K | -174.40K | -192.40K | -196.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 3.66M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.34M | 1.55M | 165.10K | 165.10K | 165.10K |
| Cash from Investing | 1.33M | 1.52M | -9.40K | -27.40K | 3.63M |
| Total Debt Issued | 7.45M | 5.70M | 700.00K | 400.00K | 18.79M |
| Total Debt Repaid | -2.86M | -3.04M | -3.36M | -1.31M | -4.39M |
| Issuance of Common Stock | 3.31M | 3.31M | 3.31M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.64M | 4.28M | 476.00K | -679.70K | 10.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -205.30K | -1.58M | -5.14M | -11.64M | 60.80K |